Some target genes include Rho GTPase Activating Proteins such as Arhgap36, and Arhgap40; Fibroblast growth factors such as Fgf3, and Fgf9. Enrichment in multiple pathways related to cancer such as Ras, Wnt, ErbB, and MAPK (Fig. 4G) was also observed. This evidence concerns the gene FGF9 and cancer.